---
measure:
  name: 20.MIPS.Mips005Rate3
  required:
    display_title: 'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or
      Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI)
      Therapy for Left Ventricular Systolic Dysfunction (LVSD)'
    inverse: false
    subject_type: Patient
    set: MIPS
    external_id: '005'
    rate_id: '3'
    version:
    internal_version: 1
  optional:
    description: Percentage of patients aged 18 years and older with a diagnosis of
      heart failure (HF) with a current or prior left ventricular ejection fraction
      (LVEF) < 40% who were prescribed ACE inhibitor or ARB or ARNI therapy either within
      a 12 month period when seen in the outpatient setting OR at each hospital discharge
    end_to_end_bonus_disabled: true
    gap_resolution_action:
    mips_measure_type: Process
    mips_high_priority: false
    mips_specialty_sets: Internal Medicine, Cardiology, Hospitalists, General Practice/Family
      Medicine
    mips_seven_point_max: false
    source_specification_url: https://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2020_Measure_005_MIPSCQM.pdf
    measure_children_names:
    - 20.MIPS.Mips005Rate1
    - 20.MIPS.Mips005Rate2
    mips_stratum:
    mips_objective:
    version: 2020
denominator:
  description:
  component_groups:
exclusion:
  description:
  reasons:
exception:
  description:
  reasons:
performance_met:
  description:
  reasons:
performance_not_met:
  description:
  reasons:
